2009, Number 1
Comparison between rocuronium and suxamethonium evaluating intubation quality and adverse effects in patients subjected to surgery
Patán-Sánchez P, Vélez-Trejo T, San Germán-Trejo LM
Language: Spanish
References: 8
Page: 14-18
PDF size: 77.72 Kb.
ABSTRACT
Objectives: To compare the clinical intubation conditions through the sketch of Domoaol between succinilcoline (suxamethonium) and rocuronium bromide at 60 seconds after their appliance, and to evaluate the side effects of such mentioned drugs. Material and methods: This was a prospective, transversal, comparative, and open study performed on 60 patients subjected to programmed surgeries, without any kind of difficulty for intubation. The patients were from both sexes, with an age ranging from 18 to 65 years old, ASA E I y II, and they were pre-medicated with midazolam (0.05 mg/kg IV); they had a non-invasive monitoring, and the induction with fentanyl (3 µg/kg), propofol (2 mg/kg IV) was randomly divided in the A group (Succinilcoline 1 mg/kg) an B group (Rocuronium 0.06 mg/kg). The results were recorded on the data collection sheet. Results: The intubation conditions for both groups were considered between good and excellent. Adverse effects were found in the 90% of the patients in A group, while in B group they were not present. Conclusion: Rocuronium bromide is one of the nondepolarizing neuromuscular relaxants that presents a quicker starting point of action and seems to be a valid option when it is necessary to obtain the upper respiratory tract very quickly.REFERENCES